Liming Shao obtained his Ph.D from University of Tokyo, and continued 3-year postdoctoral experience in Harvard University. He joined Fudan University in 2012 as a Professor of Medicinal Chemistry at School of Pharmacy. In December 2013, Dr. Shao was appointed Director of Shanghai Center for Drug Discovery and Development (SCDDD). Prior to joining Fudan University, Dr. Shao was a senior director at Sepracor Inc./Sunovion Pharmaceuticals Inc. in drug discovery research. For over 20 years, as a medicinal chemist, Dr. Shao participated in or led programs that cover a broad range of drug discovery research and development and which have resulted in 20 advanced leads for preclinical development for the treatment of pain, depression, ADHA, schizophrenia, Parkinson’s disease and the acceptance by the FDA of 4 IND applications in the US and 1 marketed drug in China. His group focuses on the drug discovery and development for CNS diseases and cancer.